Click on image to view larger version.

Fig. 7. Involvement of Sox2 as a co-activator in the Fgf response of
Xcad3. Structural features of Sox2, its derivatives and SoxD
BD() examined are illustrated at the bottom. DNA-binding HMG domains
and EnR repressor domain are marked. Experimental procedures are as described
in Fig. 5 except that the
reporter construct (546/LUC/domain2*) was used in C. (A) Effects of
dominant negative Sox2 on the Fgf response of Xcad3/LUC. The injected
amounts were 5.3 (
), 16 (
) or 48 (
) pg Sox2-EnR
mRNA/blastomere. Sox2-EnR suppresses the Fgf response of the reporter
construct (546/LUC/intron1) in a dose-dependent manner. (B) Effects of
wild-type Sox2 on the Fgf response of Xcad3/LUC. The injected amounts
were 5.3 (
), 16 (
) or 48 (
) pg Sox2 mRNA/blastomere. (C)
Reversal of Sox2-EnR induced suppression of Fgf response by wild-type Sox2.
The injected amounts were 16 pg, 96 pg and 112 pg/blastomere for Sox2-EnR,
Sox2 and EnR mRNA. Note that the suppression of reporter gene
(546/LUC/domain2*) expression induced by Sox2-EnR (
) is reversed
by the addition of Sox2 (
). (D) Effects of Sox2 BD() (
)
and SoxD BD()(
) on the Fgf response of Xcad3/LUC. The
injected amounts were 160 pg/blastomere for both Sox2 BD() and SoxD
BD() mRNA.